Skip to main content
Open Access Publications from the University of California

HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials

  • Author(s): Volk, JE;
  • Hessol, NA;
  • Gray, GE;
  • Kublin, JG;
  • Churchyard, G;
  • Mlisana, K;
  • Nchabeleng, M;
  • Buchbinder, SP;
  • Bekker, L
  • et al.
Main Content
For improved accessibility of PDF content, download the file to your device.
Current View